MAPT and tauopathy: While these data offer a mechanistic link between aberrant microglial activity and tauopathy progression, more recent studies have revealed earlier forms of tau aggregation in PS19 tau transgenic mice using a cellular FRET-based biosensor assay that utilizes recombinant repeat domain tau (RD-tau) fused to either yellow or cyan fluorescent protein.